(Q28139557)
Statements
Clinical pharmacokinetics of the CD19 receptor-directed tyrosine kinase inhibitor B43-Genistein in patients with B-lineage lymphoid malignancies (English)
0 references
December 1999
0 references
39
0 references
12
0 references
1248-55
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference